RaaschRH. Pravastatin sodium, a new HMG-CoA reductase inhibitor. DICP Ann Pharmacother1991; 25: 388–94.
2.
O'ByrneSFeelyJ. Effects of drugs on glucose tolerance in non-insulin-dependent diabetics. Drugs1990; 40: 6–18.
3.
AmeryABirkenhägerWBrixkoPBulpittCClementDDeruyttereMGlucose intolerance during diuretic therapy in elderly hypertensive patients: A second report from the European Working Party on high blood pressure in the elderly (EWPHE). Postgrad Med J1986; 62: 919–24.
4.
MurphyMBKohnerELewisPJSchumerBDolleryCT. Glucose intolerance in hypertensive patients treated with diuretics: A fourteen-year follow-up. Lancet1982; 2: 1293–5.
5.
Report of Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet1981; 2: 539–42.
6.
OfferhausL. Diuretics drugs: Metabolic consequences. In: DukesMNG, ed. Meyler's side effects of drugs. 10th ed.Amsterdam: Elsevier1984: 372.
7.
PodolskySPatavinaCG. Hyperosmolar nonketotic diabetic coma: A complication of propranolol therapy. Metabolism1973; 22: 685–93.
8.
GargAGrundySM. Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus. N Engl J Med1988; 318: 81–6.